Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gooley

Showing results (791-800 of 889) with videos related to

Pageof 89
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
Blood|April 20, 2002
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphomaAjay K Gopal, Joseph G Rajendran, Stephen H Petersdorf, et al.
Blood|November 24, 2001
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytesG E Georges, R Storb, B Bruno, et al.
British Journal of Haematology|September 2, 2008
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experienceAndrew R Rezvani, Lalitha Norasetthada, Ted Gooley, et al.
Annals of Internal Medicine|January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 CohortsGeorge B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Journal of Molecular Biology|August 29, 2021
Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2Ashish Sethi, Shoni Bruell, Tim Ryan, et al.
The Plant Journal : for Cell and Molecular Biology|March 5, 2015
SnRK1 from Arabidopsis thaliana is an atypical AMPKShane Emanuelle, Mohammed Iqbal Hossain, Isabel E Moller, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Pageof 89

Showing results (791-800 of 889) with videos related to

Sort By:
Pageof 89
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
Blood|April 20, 2002
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphomaAjay K Gopal, Joseph G Rajendran, Stephen H Petersdorf, et al.
Blood|November 24, 2001
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytesG E Georges, R Storb, B Bruno, et al.
British Journal of Haematology|September 2, 2008
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experienceAndrew R Rezvani, Lalitha Norasetthada, Ted Gooley, et al.
Annals of Internal Medicine|January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 CohortsGeorge B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Journal of Molecular Biology|August 29, 2021
Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2Ashish Sethi, Shoni Bruell, Tim Ryan, et al.
The Plant Journal : for Cell and Molecular Biology|March 5, 2015
SnRK1 from Arabidopsis thaliana is an atypical AMPKShane Emanuelle, Mohammed Iqbal Hossain, Isabel E Moller, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Pageof 89